Lower urinary tract symptoms are common after nerve damage and a new review summarizes the treatment forms and reasons behind it in patients with Parkinson disease. One of the treatment options available is intermittent catheterization.
Intermittent catheterization revolutionized the management of the neurogenic bladder in the late 1970s, in many cases replacing the need for surgery. Throughout the years, the therapy and the catheters have evolved and there is newly published research supporting the cost-effectiveness of hydrophilic coated catheters for intermittent catheterization.
You will find a summary from these articles in this blog post!
The Retrograde Idea of Jack Lapides: Clean Intermittent Catheterization.
http://www.jurology.com/article/S0022-5347(16)31867-5/fulltext
Author and Origin
Bloom DA. US.
Summary
Editorial describing the introduction of clean intermittent catheterization into clinical practice.
Conclusions
Introducing intermittent catheterization for use by patients in their home setting was groundbreaking in the late 1970s, replacing urinary diversion as the routine approach to managing the neuropathic bladder.
Comments
The Journal of Urology sheds new light on when intermittent catheterization was introduced as a general practice therapy in the 1970s.
Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic
literature review and meta-analyses.
https://bmcurol.biomedcentral.com/articles/10.1186/s12894-016-0191-1
Author and Origin
Rognoni C, Tarricone R. Italy.
Summary
Review comparing hydrophilic to non-hydrophilic coated catheters for intermittent catheterization.
Conclusions
Hydrophilic coated catheters for intermittent catheterization were found to reduce the risk of urinary tract infection (UTI).
Comments
Meta-analysis verifying previous findings of UTI risk reduction associated with use of hydrophilic-coated catheters for intermittent catheterization. (Further described in the highlight section. Open access.)
Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy.
https://www.ncbi.nlm.nih.gov/pubmed/27958390
Author and Origin
Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N. Japan.
Summary
Review of lower urinary tract symptoms (LUTS) and their treatment in Parkinson disease or multiple system atrophy.
Conclusions
Patients with Parkinson disease or multiple system atrophy often have LUTS related to overactive bladder and voiding difficulties. Exact prevalence in Parkinson disease is not established but was reported to vary between 27 and 70%.
Comments
Review summarizing the need for treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Anticholinergics and intermittent catheterization are among the treatment options.
This blog post is an extract from the Science Alert from January 2017 (76040-USX-1701)
